Statin Associated Autoimmune Myonecrosis: Case Report With Delayed Onset and Treatment Challenges
Authors:
- 14 September 2020
- journal article
- case report
- Published by SAGE Publications in Journal of Pharmacy Practice
- Vol. 35 (1) , 129-134
Abstract
Purpose: A case of delayed statin associated autoimmune myopathy (SAAM) is presented along with review of clinical findings and treatment strategies. Summary: A 54 year old male presented with proximal extremity weakness, difficulty ambulating, and dysphagia. Symptoms began when restarting atorvastatin 40 mg daily for a recent NSTEMI, following 10 years of statin use, interrupted after diagnosis of NASH. Relevant labs included CK of 13,618 IU/L, ALT/ AST of 568/407 IU/L, while additional liver, renal, and toxicology tests were normal. Following treatment response to prednisone 40 mg daily for 3 days, outpatient testing for anti-HMGCR antibodies was ordered. Twelve days from discharge, the patient was readmitted for myalgia and dysphagia, CK = 6042 IU/L, ALT/AST = 360/112 IU/L, and positive anti-HMGCR antibodies. Newly diagnosed with SAAM, symptoms improved with methylprednisolone and intravenous immunoglobulin (IVIG), continuing outpatient as daily prednisone and monthly IVIG. Four days later, the patient relapsed with worsened weakness and dysphagia, CK = 5812 IU/L, and ALT/AST = 647/337 IU/L. After response to methylprednisolone and rituximab, the patient was discharged on a corticosteroid taper, biweekly rituximab, and monthly IVIG. Two weeks later, a final admission involved a syncopal episode and fall, with a CK = 1461 IU/L. Treatment included IVIG, rituximab, and corticosteroid taper, which lead to remission for greater than 6 months. Conclusion: Statin associated autoimmune myopathy occurred when restarting atorvastatin, following 10 years of statin use. Clinical findings and positive anti-HMGCR antibodies confirmed the diagnosis. Recurrent relapses required triple combination therapy including addition of rituximab to achieve remission.Keywords
This publication has 25 references indexed in Scilit:
- Anti-HMGCR Autoantibodies in European Patients With Autoimmune Necrotizing MyopathiesMedicine, 2014
- Antibody levels correlate with creatine kinase levels and strength in anti–3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase–associated autoimmune myopathyArthritis & Rheumatism, 2012
- Understanding Statin Use in America and Gaps in Patient Education (USAGE): An internet-based survey of 10,138 current and former statin usersJournal of Clinical Lipidology, 2012
- Increased frequency of DRB1*11:01 in anti–hydroxymethylglutaryl‐coenzyme A reductase–associated autoimmune myopathyArthritis Care & Research, 2012
- 3‐hydroxy 3‐methylglutaryl coenzyme a reductase inhibition impairs muscle regenerationJournal of Cellular Biochemistry, 2012
- Statins: Past and PresentHeart Views, 2011
- Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathyArthritis & Rheumatism, 2010
- Rituximab therapy for myopathy associated with anti–signal recognition particle antibodies: A case seriesArthritis Care & Research, 2010
- Immune‐mediated necrotizing myopathy associated with statinsMuscle & Nerve, 2009
- Outcomes in 45 Patients With Statin-Associated MyopathyArchives of internal medicine (1960), 2005